NYSE$ALUR

Allurion Technologies Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Allurion's first quarter 2024 results were announced, demonstrating revenue growth and reduced cash burn.

Allurion Technologies, Inc. reported first quarter 2024 revenue of $9.4 million, a 14% increase from the fourth quarter of 2023. The company's cash burn was reduced to $8.4 million, and procedural volume increased by 12% year-over-year. They also launched the Virtual Care Suite (VCS) digital platform in the United States and closed a $48 million convertible senior secured note financing.

  • First quarter revenue reached $9.4 million, a 14% increase from the fourth quarter of 2023.
  • Procedural volume increased 12% year-over-year from the first quarter of 2023.
  • Cash burn was reduced to $8.4 million, down from $22 million in the fourth quarter of 2023.
  • The Virtual Care Suite (VCS) digital platform was launched in the United States.

Headline financials

Total Revenue

$9.39M

Previous: $14.1M-33.3%
EPS

$0.11

Previous: -$0.68+116.2%
Operating Expenses

$18.3M

No prior period
Net Operating Loss

-$11.4M

No prior period
Gross Margin

73.0%

Previous: 79.0%-7.6%
Capital Expenditures

-$104K

Previous: $277K-137.5%
Free Cash Flow

$5.48M

Previous: -$10.6M+151.7%
Net Income

$5.59M

Previous: -$17.8M+131.4%
Operating Income

-$11.4M

Previous: -$13.9M+18.0%
Gross Profit

$6.87M

Previous: $11.1M-38.3%
Cash & Equivalents

$29.7M

No prior period
Total Assets

$60M

No prior period
R&D Expense

$5.73M

No prior period
Stock-Based Comp

$552K

Previous: $409K+35.0%

Revenue & EPS history

Allurion · Revenue · Quarterly

$9.39M

Q1 2024-33.3%vs Q1 2023
Beat estimate in 5 of 8 quarters(63%)
ActualEstimate

Forward guidance

For the full year 2024, Allurion reiterates its financial guidance, expecting procedural volume growth of 20% and revenue between $60 to $65 million, with a gross margin of 77-79% and a cash burn of approximately $30 million.

Tailwinds

  • Procedural volume growth of 20%, reflecting increased penetration in key direct markets and reallocation of marketing spend to more efficient channels
  • Revenue of $60 to $65 million, reflecting 13-23% growth year-over-year
  • Gross margins of 77-79%, reflecting durable pricing of our gastric balloon
  • Initial commercialization efforts for the Allurion Virtual Care Suite SaaS product
  • Cash burn of approximately $30 million for the full year

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+1.5%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+63.8%

Avg return

30 days after

48%

10 / 21 earnings

Positive

+47.1%

Q4 2025

Best reaction

-43.7%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+25.0%+25.1%+1467.3%
Q4 2025+47.1%+35.3%+47.1%
Q3 2025+1.4%-6.0%+12.1%
Q2 2025+0.8%-8.1%-16.3%
Q1 2025+25.1%+29.7%+5.1%
Q4 2024+0.3%+3.2%-22.8%
Q3 2024-43.7%-46.2%-51.3%
Q2 2024-12.7%-17.0%-20.8%
Q1 2024-1.0%-8.8%-28.4%
Q4 2023-11.9%-11.0%-5.2%
Q3 2022+2.4%+0.7%-18.7%
Q3 2023+6.7%+2.4%-15.9%
Q2 2022-2.3%+3.8%-3.6%
Q1 2023-2.3%+3.8%-3.6%
Q2 2023-2.3%+3.8%-3.6%
Q4 2022-2.3%+3.8%-3.6%
Q1 2022+0.0%+0.2%+0.3%
Q4 2021+0.1%+0.3%-0.1%
Q3 2021-0.2%+0.0%+0.0%
Q2 2021-0.1%-0.5%-1.3%
Q1 2021+0.9%+1.0%+2.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro